NCT02597036 2025-10-23
A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors
Eli Lilly and Company
Phase 1 Terminated
Clinical Trials
9 trialsNCT05976334 2025-10-06
An Absorption, Distribution, Metabolism, Excretion (ADME) Study of [14C]Subasumstat in Adults With Advanced or Metastatic Solid Tumors
Takeda
Phase 1 Terminated
NCT05387265 2025-07-14
A Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid Tumors
CytomX Therapeutics
Phase 1 Terminated
NCT05839600 2025-07-08
A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer
Boehringer Ingelheim
Phase 1 Terminated
NCT04613492 2025-06-24
A Study of MEDI9253 in Combination With Durvalumab in Select Solid Tumors
AstraZeneca
Phase 1 Terminated
NCT04405778 2025-05-29
A Study of TAK-102 in Adult With Previously-Treated Solid Tumors
Takeda
Phase 1 Terminated
NCT05164666 2025-05-29
A Study of TAK-103 in Adult With Solid Tumors
Takeda
Phase 1 Terminated
NCT04642365 2025-05-21
A Study to Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants With Advanced Solid Tumors.
Hoffmann-La Roche
Phase 1 Terminated
NCT04237649 2025-05-18
KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors
Novartis
Phase EARLY_PHASE1 Terminated